[ad_1]
It was developed by English researchers, a clinical trial using technology to collect breath samples. These samples are used to badyze the existence of molecules likely to indicate the presence of cancer at an early stage.
This anti-cancer "breathalyzer" could potentially save thousands of lives and millions of dollars in health care costs.
Breath Biopsy Could be a Life Saving Technology
The Cambridge Center for Cancer Research in Britain is Performing a New Early Detection Test of cancer in the breath. The test is performed with the support of Owlstone Medical's Biopsy Breath .
According to what has been reported, people's breathing samples are taken during the clinical trial.
There is an urgent need to develop new tools, such as the breath test, that can help detect and diagnose cancer quickly, giving patients the best chance of surviving the disease
With this clinical trial We hope to find the signatures needed to detect early cancers – this is the next crucial step in the development of technology. Owlstone Medical's breath biopsy technology is the first to be tested on many types of cancer, potentially paving the way for a universal breathalyzer test.
Rebecca Fitzgerald, Senior Researcher at the UK Cancer Research Center [19659010] As we read in the descriptions of the survey, when cells perform biochemical reactions as part of their metabolism, they produce various VOCs.
If your metabolism changes, as in the case of cancer and in many other conditions, the cells may release a different VOC pattern. The researchers intend to identify these models using Owlstone Medical's breath biopsy technology
Patients suspected of having cancer of the esophagus and stomach will be the first
In this sense, researchers will take samples of 1,500 people, including Healthy people having to control the test, to badyze the VOCs present in the breathing.
The clinical trial begins in patients with suspected esophageal and stomach cancers and, in the coming months, extends to cancers of the prostate, kidneys, bladder, liver and pancreas .
Patients breathing for 10 minutes in a sample collection system, referenced by their family doctor, will undergo a breath test before further diagnostic tests are performed. This sample will then be processed in the breath biopsy laboratory at Owlstone Medical in Cambridge, UK.
This examination determines whether the signs of the disease are similar or not. the time to select these indicators. For people diagnosed with cancer the result is compared to samples taken from persons who did not develop the disease.
If the technology accurately identifies carcinoma the researchers hope that in the future, breath biopsy may be used in early diagnosis practices to determine whether the Patients should be referred for additional diagnostic tests.
There is a growing potential for breath testing to aid diagnosis, in addition to blood and urine tests to help doctors detect and treat diseases.
Our technology has proven extremely effective in detecting VOCs in respiration and we are proud to work with the Center for Research. of cancer, from the United Kingdom, as we seek to apply in the extremely important area which is the detection of the initial stage of several
Nearly half of the carcinomas are diagnosed late, This highlights the importance of early detection, especially for diseases such as lung cancer. esophagus, where only 12% of patients with esophageal disease have survived this disease after 10 years.
[ad_2]
Source link
